Before CBD was discussed by a President in the Oval Office, it was a medical necessity. The Charlotte Figi story is well documented — and powerful.Not because it was emotional, but because it forced a serious medical conversation. Stories like Charlotte’s change how physicians, regulators, and institutions think about where cannabinoid therapy belongs — not as a last resort, but as a legitimate option. Charlotte’s Web was built around that reality. By recognizing that cannabis does have medicinal properties — and that patients should have access to a plant-based option when it can materially improve quality of life — the company focused on trust, standards, and medical credibility first. This week, we sit down with Bill Morachnick to break down: Why CBD earned acceptance through medical trust, not consumer marketing How physician comfort, reimbursement pathways, and standards changed the conversation CBD in the Oval Office — and what that signals for the future of cannabis Chapters 00:00 Introduction to Charlotte's Web and Bill Morachnick 03:00 The Inspiring Story of Charlotte Figi 05:51 The Executive Order and Its Implications 08:59 The Role of Education in CBD Acceptance 12:12 Challenges and Misconceptions in the Cannabis Industry 15:03 The Future of CBD and Medical Recommendations 18:06 The Impact of Federal Reimbursement on CBD 21:08 Defloria and the Future of Cannabis Research 24:01 Navigating Regulatory Changes and Industry Challenges 27:03 The Importance of Quality and Consistency in CBD Products 30:02 The Potential for Pharmaceutical Collaborations 33:04 Looking Ahead: The Future of CBD and Cannabis 36:13 Final Thoughts and Audience Engagement Summary In this episode, Bryan Fields interviews Bill Morachnick, CEO of Charlotte's Web, discussing the company's inspiring origins, the recent executive order regarding CBD, and the future of cannabis as a medicinal product. Bill shares the powerful story of Charlotte Figi, whose life was transformed by CBD, and emphasizes the importance of education in changing perceptions about cannabis. The conversation also touches on the challenges faced by the industry, the potential for pharmaceutical collaborations, and the impact of federal reimbursement on CBD products. Guest Links: https://www.trycharlottesweb.com/ https://www.charlottesweb.com/ https://www.youtube.com/charlotteswebcbd https://www.instagram.com/charlotteswebcbd/ https://www.linkedin.com/in/bill-morachnick-01318a6/ https://www.linkedin.com/company/charlottesweb/ Our Links: Bryan Fields on Twitter Kellan Finney on Twitter The Dime on Twitter Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights. At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry. The Dime is a top 5% most shared global podcast The Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished. 🎥 YouTube: The Dime 📸 Instagram: The Dime https://www.newton-insights.com/
Before CBD was discussed by a President in the Oval Office, it was a medical necessity.
The Charlotte Figi story is well documented — and powerful.
Not because it was emotional, but because it forced a serious medical conversation.
Stories like Charlotte’s change how physicians, regulators, and institutions think about where cannabinoid therapy belongs — not as a last resort, but as a legitimate option.
Charlotte’s Web was built around that reality. By recognizing that cannabis does have medicinal properties — and that patients should have access to a plant-based option when it can materially improve quality of life — the company focused on trust, standards, and medical credibility first.
This week, we sit down with Bill Morachnick to break down:
Chapters
00:00 Introduction to Charlotte's Web and Bill Morachnick
03:00 The Inspiring Story of Charlotte Figi
05:51 The Executive Order and Its Implications
08:59 The Role of Education in CBD Acceptance
12:12 Challenges and Misconceptions in the Cannabis Industry
15:03 The Future of CBD and Medical Recommendations
18:06 The Impact of Federal Reimbursement on CBD
21:08 Defloria and the Future of Cannabis Research
24:01 Navigating Regulatory Changes and Industry Challenges
27:03 The Importance of Quality and Consistency in CBD Products
30:02 The Potential for Pharmaceutical Collaborations
33:04 Looking Ahead: The Future of CBD and Cannabis
36:13 Final Thoughts and Audience Engagement
Summary
In this episode, Bryan Fields interviews Bill Morachnick, CEO of Charlotte's Web, discussing the company's inspiring origins, the recent executive order regarding CBD, and the future of cannabis as a medicinal product. Bill shares the powerful story of Charlotte Figi, whose life was transformed by CBD, and emphasizes the importance of education in changing perceptions about cannabis. The conversation also touches on the challenges faced by the industry, the potential for pharmaceutical collaborations, and the impact of federal reimbursement on CBD products.
Guest Links:
Our Links:
Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
The Dime is a top 5% most shared global podcast
The Dime is a top 10 Cannabis Podcast
The Dime has a New Website. Shhhh its not finished.
🎥 YouTube: The Dime
📸 Instagram: The Dime
https://www.newton-insights.com/